about
Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphomaTax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivoHTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemiaCause-specific telomere factors deregulation in hepatocellular carcinoma.Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1.Early and transient reverse transcription during primary deltaretroviral infection of sheep.Cell dynamics and immune response to BLV infection: a unifying model.Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep.Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemiasHow mRNA is misspliced in acute myelogenous leukemia (AML)?Identification of protein features encoded by alternative exons using Exon Ontology.HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.The multiple functions of RNA helicases as drivers and regulators of gene expression.Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.Immunological alterations and associated diseases in mandrills (Mandrillus sphinx) naturally co-infected with SIV and STLV.TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs.Mosaicism of HTLV-1 5' LTR CpG methylation in the absence of malignancy.HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa.Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals.T-cell tropism of simian T-cell leukaemia virus type 1 and cytokine profiles in relation to proviral load and immunological changes during chronic infection of naturally infected mandrills (Mandrillus sphinx).An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia.Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression.The RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiation[Quality proceedings in point-of-care testing: tetanus test example]Intragenic recruitment of NF-κB drives splicing modifications upon activation by the oncogene Tax of HTLV-1
P50
Q24624263-17CA2264-C270-4EEE-BE4B-EFE6CC5E1D19Q33758754-584EA189-6BC8-4818-B1B0-8CD86B26508BQ33946851-6693BBAF-EDB5-4C3C-9D34-040AF14C237EQ34941861-8CD76AE6-D5E6-4B63-BB41-DC378EAB6364Q34982993-F9D71790-F265-41C4-9E66-CA6BD40FB2CDQ36051921-609BDDF7-6936-4B1F-BEAF-682DD312EB37Q36502550-BA1C30AA-3FA0-4FB2-AAE0-6D906C34A2A6Q36664629-326B50A1-23C8-4E64-B289-636D3751511EQ36771977-85C0FBA3-F225-4AA7-895E-11003D97E7B1Q37161179-0EC50833-BE2E-4116-ACE7-747C42C5889FQ37589603-B3B39E6C-9215-4C7F-B0FF-28494968B5A6Q38265600-35F19F4F-2CB0-4E6D-8AC6-C010C373F99CQ38434650-5C0AAC5F-334F-4778-802D-62D121E53018Q38840132-C8737390-541B-4716-81FE-6935DB82DDE3Q38850747-8D083E7F-AA0D-44A7-B514-4BD896DCF188Q38861778-E5FB9BF0-7452-463B-ACFF-3997859D8AE1Q39005049-8D78856C-852D-4CA0-A921-A7FA1933E920Q40347383-805F56C1-D3A5-4C47-8A0A-8F94BF0DE49CQ41745815-D5FDE90B-FC47-4476-AFEF-95BAABBC968CQ42269653-5AF998AC-8289-48C3-AA91-2BFA8D5A5ABBQ44640846-ACE509B1-4BF5-4731-98B1-73EDE6242F22Q45353491-3B2C1754-2A35-47B1-A225-6930EF7CED37Q45384344-3F1186E9-E972-4123-8DCA-6F8659A90798Q48735981-89250CEC-98CD-45F4-8630-7F2B350B68C6Q54634744-6D2F89B5-FF10-47DE-8586-FD7A123C6CA5Q55239285-5644998B-30E8-41C6-B37D-1E234BE7804BQ57753086-1ABC9A4E-A22A-44E3-AB51-2909DADA45E4Q84586180-BF94BED5-01AA-4A08-A3A4-F46514CCDDCBQ96431751-076AF121-6980-4466-BA75-B69692FBC91E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4840-021X
@en
name
Franck Mortreux
@ast
Franck Mortreux
@en
Franck Mortreux
@es
Franck Mortreux
@nl
type
label
Franck Mortreux
@ast
Franck Mortreux
@en
Franck Mortreux
@es
Franck Mortreux
@nl
prefLabel
Franck Mortreux
@ast
Franck Mortreux
@en
Franck Mortreux
@es
Franck Mortreux
@nl
P106
P21
P31
P496
0000-0002-4840-021X